SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vion (formerly Oncorx) interesting play on Gene Therapy
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
370 14 0 VION
Emcee:  Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
195 April 2000: First Clinical Study of Triapine Completed in Cancer Patients medicJim Oravetz-6/26/2000
194 Vion says Promycin studies halted after evaluation NEW HAVEN, Conn., June 22 (RJim Oravetz-6/22/2000
193 S8 filed today for sale of 1.5M shares. This is a part of that filing: We are aJim Oravetz-6/8/2000
192 Vion Initiates Phase I Continuous Infusion Trial of Anticancer Agent Triapine(RJim Oravetz-5/18/2000
191 Vion Pharmaceuticals Inc. (VION) received $750,000 in additional funding from tJim Oravetz-5/11/2000
190 NEW HAVEN,May 4 Vion Pharmaceuticals. Inc. (Nasdaq: VION) today announced firstJim Oravetz-5/4/2000
189 This link leads to a recently pub. article by VION Message 13478515 JimJim Oravetz-4/22/2000
188 NEW HAVEN, Conn., April 19 /PRNewswire/ -- Vion Pharmaceuticals, Inc. (Nasdaq: Jim Oravetz-4/19/2000
187 Genetically engineered salmonella in combination with radiation shown effectiveJim Oravetz-4/7/2000
186 Tuesday March 28, 9:49 am Eastern Time Company Press Release SOURCE: Vion PhaT L Comiskey-3/28/2000
185 Vion Pharmaceuticals (VION)A group led by Elliott Associates lowered its stake Jim Oravetz-3/21/2000
184 Thursday March 2, 2:44 pm Eastern Time Vion says cancer drug Phase I test compT L Comiskey-3/2/2000
183 Thursday March 2, 11:46 am Eastern Time Company Press Release SOURCE: Vion PhT L Comiskey-3/2/2000
182 Thursday March 2, 12:03 pm Eastern Time Alert: Vion Says Favorable Data Seen iT L Comiskey-3/2/2000
181 A group including Elliott Associates L.P. reduced its stake in Vion PharmaceutiJim Oravetz-2/25/2000
180 Tuesday February 22, 11:46 am Eastern Time Company Press Release SOURCE: VionT L Comiskey-2/22/2000
179 On a tip and then on a hunch I bought 3000/shrs at 14.81 The word is...we now hFiscally Conservative-2/14/2000
178 Have been following VION for years now...who would have though it would break 1Pierre Borczuk-2/10/2000
177 Shares up over Vion anti-viral licensing By Wayne E. Travers Jr., New Haven RJim Oravetz-2/9/2000
176 The good the bad and the ugly from the 2/4/00 S-3 reg form. My edited version Jim Oravetz-2/7/2000
175 Major breakout.Sr K-1/21/2000
174 NEW HAVEN ? Vion Pharmaceuticals has won a $750,000 Small Business Innovation aJim Oravetz-1/19/2000
173 The other drug: Triapine, which is designed to prevent the replication of tumorJim Oravetz-1/17/2000
172 I liked it much better in $6'ish price range. :) However, as you are awareJim Oravetz-1/17/2000
171 Jim, I'm looking for places to park some profits (like from ADIC and PERL) Scott H. Davis-1/17/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News